Chitosan Covalently Functionalized with Peptides Mapped on Vitronectin and BMP-2 for Bone Tissue Engineering.
Paola BrunAnnj ZamunerLeonardo CassariGabriella D'AuriaLucia FalcignoStefano FranchiGiorgio ContiniMartina MarsottoChiara BattocchioGiovanna IucciMonica DettinPublished in: Nanomaterials (Basel, Switzerland) (2021)
Worldwide, over 20 million patients suffer from bone disorders annually. Bone scaffolds are designed to integrate into host tissue without causing adverse reactions. Recently, chitosan, an easily available natural polymer, has been considered a suitable scaffold for bone tissue growth as it is a biocompatible, biodegradable, and non-toxic material with antimicrobial activity and osteoinductive capacity. In this work, chitosan was covalently and selectively biofunctionalized with two suitably designed bioactive synthetic peptides: a Vitronectin sequence (HVP) and a BMP-2 peptide (GBMP1a). Nuclear magnetic resonance (NMR), X-ray photoelectron spectroscopy (XPS), and Fourier transform infrared spectroscopy (FT-IR) investigations highlighted the presence of the peptides grafted to chitosan (named Chit-HVP and Chit-GBMP1a). Chit-HVP and Chit-GBMP1a porous scaffolds promoted human osteoblasts adhesion, proliferation, calcium deposition, and gene expression of three crucial osteoblast proteins. In particular, Chit-HVP highly promoted adhesion and proliferation of osteoblasts, while Chit-GBMP1a guided cell differentiation towards osteoblastic phenotype.
Keyphrases
- tissue engineering
- bone regeneration
- drug delivery
- magnetic resonance
- bone mineral density
- gene expression
- high resolution
- soft tissue
- wound healing
- end stage renal disease
- bone loss
- hyaluronic acid
- mesenchymal stem cells
- signaling pathway
- newly diagnosed
- postmenopausal women
- chronic kidney disease
- amino acid
- ejection fraction
- emergency department
- magnetic resonance imaging
- body composition
- drug release
- prognostic factors
- single molecule
- cystic fibrosis
- solid state
- biofilm formation
- pseudomonas aeruginosa
- angiotensin ii